COVID-19 Impact: Higher Risks of Severity Among Obese and Chronic Liver Disease Patients
March 23, 2021
During the COVID-19 pandemic and beyond, it will be critical for clinicians to help reverse the nation’s liver disease epidemic through early detection and monitoring of NAFLD/NASH and support lifestyle management programs.